Literature DB >> 18329923

Implantation of the Artisan iris reconstruction intraocular lens in 5 children with aphakia and partial aniridia caused by perforating ocular trauma.

Marije L Sminia1, Monica Th P Odenthal, Nitza Gortzak-Moorstein, Liesbeth J J M Wenniger-Prick, Hennie J Völker-Dieben.   

Abstract

PURPOSE: To describe the long-term clinical results of the implantation of the Artisan iris reconstruction IOL in 5 eyes of 5 children for aphakia and partial aniridia attributable to penetrating ocular trauma.
METHODS: The charts of 5 children were retrospectively reviewed. The nature and the extent of injury; age at IOL implantation; visual, refractive, and cosmetic outcome; endothelial cell density; and complications and subsequent surgical interventions were evaluated.
RESULTS: Mean follow-up period was 8.9 years (range, 4.9-12.4). Mean age at implantation of the Artisan iris reconstruction IOL was 9.5 years (range, 7.7-12.7). Visual acuity improved in 2 of 5 eyes, remained stable in 2 of 5 eyes, and decreased in 1 of 5 eyes. Complaints of photophobia were reduced, and a satisfactory cosmetic outcome was achieved in 3 of 5 patients. The mean spherical equivalent refraction error at last follow-up was -4.0 D. Mean endothelial cell loss when compared with the healthy fellow eye was 42%. Two cases were complicated by partial luxation of the IOL, one case by persistent anterior uveitis and secondary glaucoma. One eye developed a retinal detachment.
CONCLUSIONS: The Artisan iris reconstruction IOL is a treatment option for the treatment of aniridia and aphakia due to penetrating ocular trauma in children. We emphasize the high-risk characteristics of the eyes treated and the importance of careful patient selection in the outcome of the implantation of the Artisan iris reconstruction IOL.

Entities:  

Mesh:

Year:  2008        PMID: 18329923     DOI: 10.1016/j.jaapos.2007.11.014

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  8 in total

Review 1.  Is an iris claw IOL a good option for correcting surgically induced aphakia in children? A review of the literature and illustrative case study.

Authors:  R Barbara; S R Rufai; N Tan; J E Self
Journal:  Eye (Lond)       Date:  2016-07-08       Impact factor: 3.775

2.  Simultaneous correction of post-traumatic aphakia and aniridia with the use of artificial iris and IOL implantation.

Authors:  Cesare Forlini; Matteo Forlini; Robert Rejdak; Agata Prokopiuk; Oxana Levkina; Adriana Bratu; Paolo Rossini; Perfecto R Cagampang; Gian Maria Cavallini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-01-17       Impact factor: 3.117

3.  Retropupillary Fixation of Iris-Claw Intraocular Lens for Aphakic Eyes in Children.

Authors:  Martina Brandner; Sarah Thaler-Saliba; Sophie Plainer; Bertram Vidic; Yosuf El-Shabrawi; Navid Ardjomand
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

4.  Intraocular lens implantation for patients with coloboma of the iris.

Authors:  Juanjuan Li; Yan Li; Zhulin Hu; Lei Kong
Journal:  Exp Ther Med       Date:  2014-03-12       Impact factor: 2.447

5.  Implantation of ArtificialIris, a CustomFlex irisprosthesis, in a trauma patient with an Artisan lens: A case report and review.

Authors:  Farideh Doroodgar; Mahmoud Jabbarvand; Feizollah Niazi; Sana Niazi; Azad Sanginabadi
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

6.  Black Diaphragm Intraocular Lens Implantation in Patients with Aniridia.

Authors:  Sultan H Al-Rashidi
Journal:  J Ophthalmic Vis Res       Date:  2019 Jan-Mar

7.  The Influence of Decentration on Higher-Order Aberrations in Artisan Aphakic Intraocular Lens Implantation Eyes.

Authors:  Aizhu Miao; Min Zhang; Tianhui Chen; Yi Lu
Journal:  J Ophthalmol       Date:  2020-04-09       Impact factor: 1.909

8.  Novel surgical technique of sutureless artificial iris and intraocular lens scleral fixation using Yamane technique.

Authors:  Daniel Rudolf Muth; Siegfried Georg Priglinger; Mehdi Shajari; Thomas Christian Kreutzer; Wolfgang Johann Mayer
Journal:  Am J Ophthalmol Case Rep       Date:  2022-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.